Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034241-03
Application #
2069333
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1993-11-15
Project End
1997-10-31
Budget Start
1995-11-01
Budget End
1996-10-31
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Pathology
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Robinson, H L; Montefiori, D C; Johnson, R P et al. (2000) DNA priming and recombinant pox virus boosters for an AIDS vaccine. Dev Biol (Basel) 104:93-100
Robinson, H L; Pertmer, T M (2000) DNA vaccines for viral infections: basic studies and applications. Adv Virus Res 55:Jan-74
Robinson, H L; Montefiori, D C; Johnson, R P et al. (1999) Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med 5:526-34
Robinson, H L (1999) DNA vaccines: basic mechanism and immune responses (Review). Int J Mol Med 4:549-55
Richmond, J F; Lu, S; Santoro, J C et al. (1998) Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol 72:9092-100
Lu, S; Wyatt, R; Richmond, J F et al. (1998) Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. AIDS Res Hum Retroviruses 14:151-5
Robinson, H L (1997) DNA vaccines for immunodeficiency viruses. AIDS 11 Suppl A:S109-19
Lu, S; Manson, K; Wyand, M et al. (1997) SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups. Vaccine 15:920-3
Robinson, H L; Torres, C A (1997) DNA vaccines. Semin Immunol 9:271-83
Richmond, J F; Mustafa, F; Lu, S et al. (1997) Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting. Virology 230:265-74

Showing the most recent 10 out of 13 publications